secwatch.observer — SEC 8-K summary
======================================

Issuer:     Covista Inc. (CVSA)
CIK:        0000730464
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0000730464-25-000007
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adtalem Q3 FY2025 EPS $1.59 ($1.92 adj.), revenue $466.1M +12.9%; raises FY guidance
--------------------------------------------------------------------------------

- Revenue $466.1M (+12.9% YoY); diluted EPS $1.59 (adj. $1.92, +28% YoY); net income $60.8M.
- Total enrollment up 9.8% to 94,223; Chamberlain +6.8%, Walden +13.5%, Med/Vet +1.2%.
- Completed $300M share repurchase program; new $150M authorization through May 2028.
- FY2025 guidance raised: revenue $1,760-1,775M, adj. EPS $6.40-$6.60 (28-32% YoY growth).
- Adjusted EBITDA $127.8M (+19.3% YoY); margin 27.4% vs 25.9% prior year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730464/000073046425000007/0000730464-25-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730464/000073046425000007/atge-20250508x8k.htm
  HTML page:      https://secwatch.observer/filing/0000730464-25-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer